CED, the Southeast’s largest entrepreneurial support organization, today announced the agenda and speakers for the CED Life Science Conference 2013, February 27-28, 2013, in Raleigh, North Carolina. The North Carolina Biotechnology Center and North Carolina Biosciences (NCBIO) are presenting partners.
The keynote speakers at the CED Life Science Conference 2013 are N. Anthony (Tony) Coles, M.D., chairman and CEO, Onyx Pharmaceuticals, Inc.; Dr. Samuel Nussbaum, M.D., executive vice president, Clinical Health Policy and chief medical officer, WellPoint, Inc.; and Jack W. Szostak, Ph.D., recipient of the 2009 Nobel Prize in physiology or medicine, investigator, Howard Hughes Medical Institute, and professor of genetics, Harvard Medical School.
The conference co-chairs are David P. King, CEO, LabCorp; Ed Mathers, partner, NEA; and Bradley Wilson, president and CEO, Blue Cross and Blue Shield of North Carolina. The CED Life Science Conference attracts more than 1,000 life science entrepreneurs, investors and industry professionals.
Early registration discounts are available through January 25, 2013. To register or view the full conference agenda, visit the CED Life Science Conference 2013 site at http://www.cednc.org/lifescience.
“This conference is a must-attend event for those in the life science industry,” said David King, CEO of LabCorp, who will lead a panel on leadership. “We have secured an impressive lineup of opinion leaders, who will speak to the critical challenges and opportunities that lie ahead.”
“The conference represents the largest regional gathering of the life science community,” said CED president Joan Siefert Rose. “This year’s program includes a showcase of up-and-coming companies, updates on policy affecting the industry, and excellent opportunities for high-level networking,” Rose said. The conference is now in its 22nd year.